1. Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatric Research 1: 249–154
2. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979–980
3. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: Selective destruction of minergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine. Proceedings of the National Academy of Science, USA 80: 4546–4550
4. Langston JW, Forno LS, Rebert CS, and Irwin I (1984) Selective nigral toxicity after systemic administration of 1-methyl-4- phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Research 292: 390–394
5. Tetrud JW, Langston JW, Redmond DE, Jr., Roth RH, Sladek JR, Jr., Angel RW (1986) MPTP-induced tremor in human and non-human primates. Neurology 36: 308